Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MAT | AS |
|---|---|---|
| Price | $16.05 | $27.47 |
| Change today | ▲ 5.11% | ▲ 1.10% |
| Market cap | $4.59B | $15.98B |
| Return, 3 months | +19.6% | -19.3% |
| Return, year to date | -19.1% | -26.5% |
| Return, 1 year | -11.2% | -19.5% |
| P/E (TTM) | 12.0 | 28.6 |
| P/B | 2.3 | 2.3 |
| P/E percentile vs own 5y | – | 42nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +32.1% |
| Net profit growth (YoY) | – | +425.9% |
| Gross margin | – | 59.8% |
| Operating margin | – | 13.0% |
| Net margin | – | 7.3% |
| Return on equity | – | 8.8% |
| Analyst target vs. price | +13.0% | +69.1% |
| Analyst buy share | 60% | 93% |
| RSI (14) | 70 | 43 |
| 30-day volatility | 60.6% | 35.9% |
| Max drawdown, 1 year | -42.9% | -37.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
